F. Delphin-Combe

发表

Initial and long-term evaluation of patients with Alzheimer’s after hospitalization in cognitive and behavioural units: the EVITAL study design

B. Laurent, P. Krolak-Salmon, I. Rouch, 2014, BMC Psychiatry.

[Experience of a care pathway for psychological and behavioral symptoms of dementia].

François Husson, P. Krolak-Salmon, I. Rouch, 2013, Geriatrie et psychologie neuropsychiatrie du vieillissement.

An innovative therapeutic educational program to support older drivers with cognitive disorders: Description of a randomized controlled trial study protocol

M. Ranchet, P. Krolak-Salmon, L. Paire-Ficout, 2022, Frontiers in neurology.

Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial

F. Collette, J. Molinuevo, A. Lutz, 2022, Alzheimer's research & therapy.

[Effectiveness of a cognitive-behavioral unit on behavioral and psychological symptoms of dementia].

P. Krolak-Salmon, I. Rouch, F. Delphin-Combe, 2013, Revue neurologique.

Altered Affective Evaluations of Smells in Alzheimer's Disease.

M. Bensafi, C. Rouby, P. Joussain, 2015, Journal of Alzheimer's disease : JAD.

Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2017, Alzheimer's Research & Therapy.

Impact of Cognitive, Functional, Behavioral Disorders, and Caregiver Burden on the Risk of Nursing Home Placement.

P. Krolak-Salmon, Marine Dufournet, F. Delphin-Combe, 2019, Journal of the American Medical Directors Association.

Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial

F. Collette, F. Jessen, J. Molinuevo, 2021, Psychotherapy and Psychosomatics.

Relationship Between Comorbidities in Patients With Cognitive Complaint and Caregiver Burden: A Cross-Sectional Study.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.

First-order Affective Theory of Mind in Persons with Alzheimer’s Disease and in Healthy Older Adults

H. Chainay, G. Michael, P. Krolak-Salmon, 2018, Canadian Journal on Aging / La Revue canadienne du vieillissement.

Memory for faces with emotional expressions in Alzheimer’s disease and healthy older participants: positivity effect is not only due to familiarity

H. Chainay, P. Krolak-Salmon, Alina-Alexandra Sava, 2017, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Neurocognitive disorders: what are the prioritized caregiver needs? A consensus obtained by the Delphi method

P. Krolak-Salmon, C. Mouchoux, M. Kossovsky, 2018, BMC Health Services Research.

A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol

P. Krolak-Salmon, C. Mouchoux, I. Rouch, 2019, BMC Geriatrics.

Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study.

P. Krolak-Salmon, C. Mouchoux, I. Rouch, 2015, Journal of Alzheimer's disease : JAD.

Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature.

A. Vighetto, S. Lehmann, A. Gabelle, 2014, Journal of Alzheimer's disease : JAD.

Relationship between anxiety and cognitive performance in an elderly population with a cognitive complaint

P. Krolak-Salmon, B. Fantino, I. Rouch, 2016, European journal of neurology.

Blunted emotion judgments of body movements in Parkinson’s disease

C. Schmitz, B. Tillmann, M. Hénaff, 2021, Scientific Reports.

Application of the European Test of Olfactory Capabilities in patients with olfactory impairment

M. Bensafi, C. Rouby, P. Joussain, 2016, European Archives of Oto-Rhino-Laryngology.

Determinants of Medical Direct Costs of Care among Patients of a Memory Center

P. Krolak-Salmon, H. Späth, F. Delphin-Combe, 2021, The Journal of Prevention of Alzheimer's Disease.

[Effect of a non-pharmacological intervention, Voix d'Or(®), on behavior disturbances in Alzheimer disease and associated disorders].

P. Krolak-Salmon, I. Rouch, F. Delphin-Combe, 2013, Geriatrie et psychologie neuropsychiatrie du vieillissement.

Risk Factors of Caregiver Burden Evolution, for Patients With Subjective Cognitive Decline or Neurocognitive Disorders: A Longitudinal Analysis.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.

Immediate Benefit of Art on Pain and Well-Being in Community-Dwelling Patients with Mild Alzheimer's

B. Tillmann, B. Laurent, J. Dorey, 2019, American journal of Alzheimer's disease and other dementias.

Proposition of a corrected measure of the Lawton instrumental activities of daily living score

J. Dorey, P. Krolak-Salmon, Marine Dufournet, 2021, BMC Geriatrics.

Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2017, Alzheimer's Research & Therapy.

PHARMAID study protocol: Randomized controlled trial to assess the impact of integrated pharmaceutical care at a psychosocial intervention on caregiver's burden in Alzheimer's disease or related diseases.

P. Krolak-Salmon, C. Colin, C. Mouchoux, 2017, Contemporary clinical trials.

Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature.

A. Vighetto, S. Lehmann, A. Gabelle, 2014, Journal of Alzheimer's disease : JAD.

Relationship Between Comorbidities in Patients With Cognitive Complaint and Caregiver Burden: A Cross-Sectional Study.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.